Home > News

News

Allergic to the cure: Researchers create a new and quicker way to detect platin drug allergies for cancer patients

Platins, the most widely used chemotherapeutic drugs, are displaying an alarming rise in drug hypersensitivity reactions much more severe than the watery eyes or runny noses associated with hay fever, which is also a Type 1, immediate hypersensitivity reaction. A Notre Dame-led team has developed a safer way of determining hypersensitivity in patients.

>Full Story

Chang to receive AES Lifetime Achievement Award

Hsueh-Chia Chang, the Bayer Professor of Chemical and Biomolecular Engineering at the University of Notre Dame, has been selected to receive the AES Lifetime Achievement Award.

>Full Story

Matthew Webber receives American Diabetes Association’s Accelerator Award

nwelding • Date: February 19, 2019

The American Diabetes Association has announced that it will fund a $1.625 million Accelerator Award to Matthew Webber, assistant professor in the Department of Chemical and Bimolecular Engineering at the University of Notre Dame, to research and develop materials capable of sensing critical drops in blood glucose.

>Full Story

Notre Dame faculty members named to top one percent of highly cited researchers list for 2018

nwelding • Date: February 5, 2019

Professors Martin Haenggi and Prashant V. Kamat have been named to the Clarivate Analytics’ 2018 Highly Cited Researchers list.

>Full Story

More than a decade as a chief editor, always a pioneer

nwelding • Date: January 24, 2019

In December 2018, after 12 years of leadership, Hsueh-Chia Chang, the Bayer Professor of Chemical and Biomolecular Engineering at the University of Notre Dame, stepped down as the founding and chief editor of Biomicrofluidics.

>Full Story
Filed under:
In the News Archives